Antitope to Present at the Oxford Global Proteins Congress 2008, Berlin, Germany, 20th November 2008

Dr. Frank Carr, Director for Biologics Research of Antitope, will give a presentation on "Selection and Design of Therapeutic Antibodies with Reduced Immunogenicity " at the Proteins Congress 2008, Berlin, Germany, 20th November 2008.

Dr Carr's presentation will discuss the risk factors associated with the immunogenicity of biologics, accurate detection of T cell epitopes in biologics, case studies highlighting the link between clinical immunogenicity and T cell epitopes and re-engineering strategies to avoid or remove T cell epitopes.

For more information, visit the conference website at http://www.proteins-congress.com/